Cortical projection neurons with distinct axonal connectivity employ ribosomal complexes with distinct protein compositions
Curation statements for this article:-
Curated by eLife
eLife Assessment
This study presents a valuable and rigorous molecular resource, offering subtype-specific insight into the composition of ribosome-associated protein complexes in the developing cerebral cortex. The evidence is compelling in terms of data quality and is strongly supported by the results, given the rigorous technical execution. However, the findings remain primarily descriptive, as the study lacks functional validation to support mechanistic conclusions.
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (eLife)
Abstract
Diverse subtypes of cortical projection neurons (PN) form long-range axonal projections that are responsible for distinct sensory, motor, cognitive, and behavioral functions. Translational control has been identified at multiple stages of PN development, but how translational regulation contributes to formation of distinct, subtype-specific long-range circuits is poorly understood. Ribosomal complexes (RCs) exhibit variations of their component proteins, with an increasing set of examples that confer specialized translational control. Here, we directly compare the protein compositions of RCs in vivo from two closely related cortical neuron subtypes–cortical output “subcerebral PN” (SCPN) and interhemispheric “callosal PN” (CPN)– during establishment of their distinct axonal connectivity. Using retrograde labeling of subtype-specific somata, purification by fluorescence-activated cell sorting, ribosome immunoprecipitation, and ultra-low-input mass spectrometry, we identify distinct protein compositions of RCs from these two subtypes. Strikingly, we identify 16 associated proteins reliably and exclusively detected only in RCs of SCPN. 11 of these proteins have known interaction with components of ribosomes; we further validated ribosome interaction with protein kinase C epsilon (PRKCE), a candidate with roles in synaptogenesis. PRKCE and a subset of SCPN-specific candidate ribosome-associated proteins also exhibit enriched gene expression by SCPN. Together, these results indicate that ribosomal complexes exhibit subtypespecific protein composition in distinct subtypes of cortical projection neurons during development, and identify potential candidates for further investigation of function in translational regulation involved in subtype-specific circuit formation.
Article activity feed
-
eLife Assessment
This study presents a valuable and rigorous molecular resource, offering subtype-specific insight into the composition of ribosome-associated protein complexes in the developing cerebral cortex. The evidence is compelling in terms of data quality and is strongly supported by the results, given the rigorous technical execution. However, the findings remain primarily descriptive, as the study lacks functional validation to support mechanistic conclusions.
-
Reviewer #1 (Public review):
This work provides a valuable toolkit for endogenous isolation of projection neuron subtypes. With further validation, it could present a solid method for low-input ribosome affinity purification using a ribosomal RNA (rRNA) antibody. The experimental evidence for the distinct ribosomal complexes is limited to this method and indirect support from complementary analyses of pre-existing data. However, with additional experimental data to support the specificity of ribosomal complex pulldown and confirmation of the putative ribosomal complex proteins of interest, the study would provide compelling evidence for translation regulation of neuronal development through compositional ribosome heterogeneity. This work would be of interest to neuroscientists, developmental biologists, and those studying translational …
Reviewer #1 (Public review):
This work provides a valuable toolkit for endogenous isolation of projection neuron subtypes. With further validation, it could present a solid method for low-input ribosome affinity purification using a ribosomal RNA (rRNA) antibody. The experimental evidence for the distinct ribosomal complexes is limited to this method and indirect support from complementary analyses of pre-existing data. However, with additional experimental data to support the specificity of ribosomal complex pulldown and confirmation of the putative ribosomal complex proteins of interest, the study would provide compelling evidence for translation regulation of neuronal development through compositional ribosome heterogeneity. This work would be of interest to neuroscientists, developmental biologists, and those studying translational networks underlying gene regulation.
Strengths
(1) This in vivo labeling of specific projection neurons and ribosomal rRNA affinity purification method accommodates a low input of <100K somata per replicate, which is useful for the study of neuronal subtypes with limited input. In principle, this set of techniques could work across different cell types with limited input, depending on the molecule used for cell type labeling.
(2) The authors are also able to isolate endogenous neurons with minimal perturbation up to the point of collection, preserving the native state for the neuron in vivo as long as possible prior to processing.
(3) This study identified over a dozen potential non-ribosomal proteins associated with SCPN ribosomal complexes, as well as a ribosomal protein enriched in CPN.
Limitations
(1) In this study, the authors address the advantages of their ribosomal complex isolation method in SCPN and CPN against RPL22-HA affinity purification. While this does show more pull-down of the ribosomal RNA by the Y10B rRNA antibody, the authors claim this method identifies cell-type-specific ribosomal complex proteins without demonstrating a positive control for the method's specificity. There are very limited experiments to truly delineate how "specific" this method is working and whether there could be contamination from other complexes bound by the antibody. I see this as the major limitation that should be addressed. To boost their claims of capturing cell-type-specific ribosomal complexes, the authors could consider applying their rRNA affinity purification pipeline to compare cell types with well-characterized ribosome-associated proteins, like mouse embryonic stem cells and HELA cells. The reviewer can completely appreciate the elegance in the neural characterization here, but it seems there needs to be a solid foothold on the specificity of the method, perhaps facilitated by cell types that can be more readily scaled up and tested.
(2) The authors followed up on their differentially enriched ribosomal complex proteins by analyzing the ribosome association of these proteins in external datasets. While this analysis supports the ribosome-association of these proteins, there is limited experimental validation of physical association with the ribosome, much less any functional characterization. The reciprocal pulldown of PRKCE is promising; however, I would recommend orthogonal validation of several putative ribosomal complex proteins to increase confidence. Specifically, the authors could use sucrose gradient fractionation of SCPN and CPN, followed by a western blot to identify the putative interaction with the 80S monosome or polysomes. This would also provide evidence towards the pulldown capturing association with mature ribosome species, which is currently unclear. This experiment would provide substantial evidence for the direct association of these non-ribosomal proteins with subtype-specific ribosomal complexes.
(3) The authors state interest in learning more about the differences underlying translational regulation of projection neuron development. This method only captures neuronal somata, which will only capture ribosomes in the main cell body. There are also ribosomes regulating local translation in the axons, which may also play a critical role in axonal circuit establishment and activity. These ribosomal complex interactions may also be rather transient and difficult to capture at only one developmental stage. Therefore, this method is currently limited to a single developmental snapshot of ribosomal complexes at P3 within the main cell body. It would be exciting to see the extended utility of this method to sample neurites and additional developmental stages to gain further resolution on the developmental translation regulation of these projection neurons.
Likely impact of the work on the field, and the utility of the methods and data to the community:
The authors introduce a unique pipeline of techniques to identify cell-type-specific ribosomal complex compositions. With more validation, there is certainly potential for those studying neuronal translation to leverage this method in limited primary cells as an alternative to existing methods that do not rely on ribosomal protein tagging, such as ARC-MS (Bartsch et al., 2023), RAPIDASH (Susanto and Hung et al., 2024), and RAPPL (Nature Communications, 2025).
-
Reviewer #2 (Public review):
Summary:
This study presents a sophisticated molecular dissection of ribosome-associated complexes (RCs) in two well-defined cortical projection neuron subtypes (ScPN and CPN) during early postnatal development. The authors develop and optimize an rRNA immunoprecipitation-mass spectrometry (rRNA IP-MS) workflow to recover RCs from FACS-purified, retrogradely labeled neurons, achieving remarkable subtype specificity and biochemical resolution. Through proteomic profiling, they reveal both shared and distinct ribosome-associated proteins between ScPN and CPN, with a focus on non-core RC components and their potential functional relevance. The work advances our understanding of cell-type-specific translation regulation, moving beyond the transcriptome to explore the proteome-level complexity in neuronal subtypes.
Reviewer #2 (Public review):
Summary:
This study presents a sophisticated molecular dissection of ribosome-associated complexes (RCs) in two well-defined cortical projection neuron subtypes (ScPN and CPN) during early postnatal development. The authors develop and optimize an rRNA immunoprecipitation-mass spectrometry (rRNA IP-MS) workflow to recover RCs from FACS-purified, retrogradely labeled neurons, achieving remarkable subtype specificity and biochemical resolution. Through proteomic profiling, they reveal both shared and distinct ribosome-associated proteins between ScPN and CPN, with a focus on non-core RC components and their potential functional relevance. The work advances our understanding of cell-type-specific translation regulation, moving beyond the transcriptome to explore the proteome-level complexity in neuronal subtypes.
Strengths:
This work stands out for its technical sophistication and innovation. The authors combine retrograde labeling, FACS purification, and an optimized rRNA IP-MS approach (low input) to isolate ribosome-associated complexes from highly specific neuronal subtypes in vivo, a challenging issue that they execute with impressive rigor. The methodological pipeline is both elegant and well-controlled, yielding high-quality, reproducible data. The depth of proteomic coverage is remarkable, with nearly all known cytoplasmic ribosomal proteins identified, along with hundreds of ribosome-associated proteins (RAPs), including translation factors, chaperones, and RNA-binding proteins. The analysis not only reveals shared components between ScPN and CPN RCs but also uncovers subtype-specific differences in associated proteins.
Particularly notable is the integration of this new proteomic dataset with previously published transcriptomic and ribosome footprinting data, which helps to validate the specificity and relevance of the findings. Overall, the clarity of the writing, the robustness of the data, and the transparency of the methods make this a strong and compelling contribution.
Weaknesses:
Despite the depth and high quality of the dataset, the study remains descriptive. While the identification of subtype-specific RC components is intriguing, the current version of the manuscript does not explore their functional roles or the biological consequences of their alterations. There is no perturbation, causal testing, in vitro or in vivo manipulation to demonstrate whether these proteins are necessary for ScPN or CPN identity, specific axonal targeting, metabolism, or synaptic function.
One important point highlighted by the authors in the discussion - and critical for establishing the subtype specificity of the identified proteins - is that some ribosomal complexes may be specialized for specific developmental stages, rather than exclusively for the subtype-specific needs of projection neuron development. The work presented here provides a valuable starting point for further investigation into such RC specialization. However, it will be essential to determine to what extent these RCs exhibit true subtype specificity, independently of their temporal maturation context.
As a result, key mechanistic insights remain a bit speculative. Although several of the identified proteins have known roles in processes like synaptogenesis or metabolism, their relevance to the specific neuronal subtypes under study is not experimentally addressed. That said, given its rich content and the comprehensive early postnatal dataset, the manuscript represents an extremely valuable resource for the community. While primarily exploratory, it lays a strong foundation for future functional studies aimed at uncovering the biological impact of the identified ribosomal complexes.
-
